Cancer, cardiovascular diseases, and metabolic diseases like diabetes, are the main cause of mortality and disability in present times. Even with the understanding of scientific disease indications, it is crucial to elevate diagnosis and control the symptoms and signs of illness.
According to the Future Market Insights’ analysis, the Injectable Drugs Market is set to grow at a 5.8% CAGR over the assessment period. As per the report, the market is projected to be valued at US$ 937.0 Bn by the end of 2032.
Advancements in technologies that involve optimization of the devices used for clinical conditions, be it chronic or acute, clinical innovations, bringing in minimally invasive treatments, and evolvement in clinical diagnostics and management in treating high-risk patients, are the key developments within the general healthcare industry.
Download Sample Report to learn about recent in the Injectable Drugs Market observed by FMI @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15073
Demand for related treatments is increasing, as people are now more aware of the right treatment options, doctor-guided plans, and precautionary measures to consider for serious clinical conditions.
Key players in the injectable drugs market are actively seeking to gain approvals from regulatory bodies, and develop products across the continuum of care in severe case recovery. Furthermore, the FDA is expected to approve new devices related to advanced injectable drugs and their administration, over the coming years.
“Increasing incidence of infectious diseases, oncological diseases, cardiac disorders and device innovation are prompting healthcare providers to incorporate new treatment regimens for improved patient outcome,” says an FMI analyst.
Key Takeaways:
- By product, monoclonal antibodies held the largest share of 5%in the global market in 2021.
- Based on application, infectious diseases segment held the largest share of 4%in the global market in 2021, with the segment expected to expand at 7% CAGR over the forecast period.
- In terms of molecule, large molecule segment held the largest share of 8%in the global market in 2021.
- By route of administration, sales in the intravenous (IV) segment are expected to increase at a 3%CAGR over the assessment period.
- Based on distribution channel, the hospital pharmacies segment was valued at US$ 231.0 Bnin 2021.
- North America held the largest share of 5%in the global injectable drugs treatment market in 2021, owing to the growing government investments in healthcare and R&D activities.
Questioning the foundations: Examining the underlying assumptions of the study. Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15073
Competitive Landscape
Product launches and collaborations with suppliers that have a strong position and are popular in the market are some of the key strategies of the market players operating in the global injectable drugs market. For instance:
- Merck and Gilead Sciences, Inc. (Gilead) signed an agreement in March 2021 to collaborate on the development and commercialization of long-acting HIV treatments that combine Merck’s investigational nucleoside reverse transcriptase translocation inhibitor islatravir and Gilead’s investigational capsid inhibitor lenacapavir.
- In March 2022, Sanofi IGM Biosciences, Inc. today announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets. Engineered IgM antibodies represent a new class of potential therapeutics that combine the multi-valency of IgM antibodies possessing 10 binding sites compared to conventional IgG antibodies having only 2 target binding sites.
- In February 2022, Novartis India Limited extends access to its medicines in India by signing exclusive sales and distribution agreement with Dr. Reddy’s Laboratories
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the injectable drugs market in its latest study, presenting a historical demand assessment of 2014 – 2021 and projections for 2022 – 2032.
The research study is based on the product – (monoclonal antibodies, immunoglobulin, cytokines, insulin, peptide hormones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, chemotherapy agents, and others), by application (oncology, infectious diseases, diabetes, blood disorders, hormonal disorders, musculoskeletal disorders, CNS diseases, pain management, and cardiovascular diseases), by molecule type (small molecules and large molecules), by route of administration (intravenous (IV), intramuscular (IM), and subcutaneous (SC)), by distribution channel (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), across seven key regions of the world.
Ignite Your Passion for Learning with in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-15073
Key Players :
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- AstraZeneca Plc
- Merck & Co., Inc.
- Viatris + Mylan N.V
- Cipla Inc.
- Reddy’s Laboratories Ltd.
- Samsung Biologics
- Abbott Laboratories
- Amgen Incorporated
- Baxter International Incorporated
- Becton Dickinson and Company
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Roche Holding Limited
Key Segments Covered in Injectable Drugs Industry Research
By Product:
- Monoclonal Antibodies
- Immunoglobulin
- Cytokines
- Insulin
- Peptide Hormones
- Blood Factors
- Peptide Antibiotics
- Vaccines
- Small Molecule Antibiotics
- Chemotherapy Agents
- Others
By Application:
- Oncology
- Infectious Diseases
- Diabetes
- Blood disorders
- Hormonal Disorders
- Musculoskeletal Disorders
- CNS Diseases
- Pain Management
- Cardiovascular Diseases
By Molecule Type:
- Small Molecules
- Large Molecules
By Route of Administration:
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
More Trending Reports by Future Market Research:
Prosthetic Heart Valve Market: The global prosthetic heart valve market size was valued at US$ 10.9 Billion in 2021 and it is likely to touch a valuation of US$ 12.3 Billion by the end of 2022. With the rising prevalence of valvular disorders such as aortic stenosis (AS), organic and ischemic (functional) mitral regurgitation, and tricuspid regurgitation, the overall demand for prosthetic valves is projected to grow at a prolific CAGR of 11.4% between 2022 and 2032, totaling US$ 36.3 Billion by 2032..
North America Vision Care Market: North America vision care market is projected to register a CAGR of 9.8% during the forecast period and is expected to be valued at US$ 100.72 Bn by the end of 2026.
North America Outbound Medical Tourism Services Market : Outbound medical tourism in North America is rising substantially as a result of an increasing number of people from the region opting for cross border treatment. Cross border countries offer medical treatments at significantly low costs. According to a 2014 International Medical Tourism Journal study, the cost of treatment in the U.S. is 85% higher than that offered in countries like India, Mexico, etc. For instance, treatments such as knee replacement costing around US$ 35,000 to US$ 60,000 in the U.S. cost less than US$ 20,000 in Costa Rica and India, inclusive of lodging and airfare costs
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube